Inspire Medical Systems Inc- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Inspire Medical Systems Inc 公司

Inspire Medical Systems, Inc. 是一家医疗技术公司。该公司专注于为阻塞性睡眠呼吸暂停 (OSA) 患者开发和商业化先进的微创解决方案。其专有的 Inspire 疗法是经 FDA 批准的神经刺激技术，可为中度至重度阻塞性睡眠呼吸暂停提供安全有效的治疗。该公司开发了一种新颖的闭环解决方案，可以持续监测患者的呼吸并提供轻度舌下神经刺激以保持气道畅通。该公司通过直销组织向美国 (US) 和欧洲和日本部分国家的医院和门诊手术中心 (ASC) 销售其 Inspire 系统，并通过分销商在新加坡和香港销售其 Inspire 系统。其直销团队从事针对耳鼻喉 (ENT) 医生和睡眠中心的销售工作和促销活动。

公司简介

公司代码INSP

公司名称Inspire Medical Systems Inc

上市日期May 03, 2018

CEOMr. Timothy P. (Tim) Herbert

员工数量1246

证券类型Ordinary Share

年结日May 03

公司地址5500 Wayzata Blvd Ste 1600

城市GOLDEN VALLEY

上市交易所NYSE Consolidated

国家United States of America

邮编55416-1237

电话17639575037

网址https://www.inspiresleep.com/

公司代码INSP

上市日期May 03, 2018

CEOMr. Timothy P. (Tim) Herbert

公司高管

名称

名称/职务

职务

持股

持股变动

Mr. Timothy P. (Tim) Herbert

Chairman of the Board, President, Chief Executive Officer

77.13K

-79.27%

Mr. Shawn T. Mccormick

Independent Director

31.05K

+14.79%

Mr. Casey M. Tansey

Independent Director

23.01K

+0.58%

Mr. Bryan K. Phillips, J.D.

Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary

6.36K

-43.33%

Mr. Jason P. Kelly

Chief Manufacturing and Quality Officer

4.54K

--

Ms. Shelley G. Broader

Independent Director

4.12K

+3.72%

Dr. Myriam J. Curet, M.D.

Independent Director

3.37K

+60.29%

Mr. John C. Rondoni

Chief Technology Officer

--

Mr. Carlton W. Weatherby

Chief Strategy and Growth Officer

--

Ms. Georgia Garinoismelenikiotou

Independent Director

--

名称

名称/职务

职务

持股

持股变动

Mr. Timothy P. (Tim) Herbert

Chairman of the Board, President, Chief Executive Officer

77.13K

-79.27%

Mr. Shawn T. Mccormick

Independent Director

31.05K

+14.79%

Mr. Casey M. Tansey

Independent Director

23.01K

+0.58%

Mr. Bryan K. Phillips, J.D.

Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary

6.36K

-43.33%

Mr. Jason P. Kelly

Chief Manufacturing and Quality Officer

4.54K

--

Ms. Shelley G. Broader

Independent Director

4.12K

+3.72%

收入明细

单位: USD更新时间: 7月6日周日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

United States

193.61M

96.17%

All other countries

7.71M

3.83%

业务

地区

暂无数据

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.80%

The Vanguard Group, Inc.

10.81%

Dragoneer Investment Group, LLC

7.96%

Fidelity Management & Research Company LLC

6.42%

Wasatch Global Investors Inc

5.53%

其他

57.48%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

11.80%

The Vanguard Group, Inc.

10.81%

Dragoneer Investment Group, LLC

7.96%

Fidelity Management & Research Company LLC

6.42%

Wasatch Global Investors Inc

5.53%

其他

57.48%

股东类型

持股股东

占比

Investment Advisor

61.85%

Investment Advisor/Hedge Fund

32.43%

Hedge Fund

8.29%

Private Equity

7.96%

Research Firm

2.76%

Pension Fund

2.46%

Individual Investor

1.26%

Sovereign Wealth Fund

0.90%

Bank and Trust

0.84%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

883

35.48M

119.97%

-4.91M

2025Q1

912

35.71M

121.08%

-5.66M

2024Q4

874

35.22M

118.69%

-4.72M

2024Q3

852

35.48M

118.45%

-2.86M

2024Q2

825

33.60M

112.73%

-2.85M

2024Q1

801

33.20M

111.87%

-2.01M

2023Q4

786

32.35M

109.45%

+751.92K

2023Q3

753

29.93M

101.80%

-635.63K

2023Q2

727

29.57M

101.94%

-987.85K

2023Q1

680

29.78M

102.13%

-573.41K

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

3.60M

12.2%

-96.27K

-2.61%

Mar 31, 2025

The Vanguard Group, Inc.

3.22M

10.91%

-44.71K

-1.37%

Mar 31, 2025

Dragoneer Investment Group, LLC

1.30M

4.4%

+426.49K

+48.96%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.02M

6.86%

-48.18K

-2.33%

Mar 31, 2025

Wasatch Global Investors Inc

1.52M

5.17%

+202.34K

+15.31%

Mar 31, 2025

Baillie Gifford & Co.

1.16M

3.93%

-96.25K

-7.66%

Mar 31, 2025

State Street Global Advisors (US)

1.01M

3.42%

-54.09K

-5.09%

Mar 31, 2025

William Blair Investment Management, LLC

692.92K

2.35%

-209.69K

-23.23%

Mar 31, 2025

Frontier Capital Management Company, LLC

433.49K

1.47%

+14.63K

+3.49%

Mar 31, 2025

Janus Henderson Investors

642.76K

2.18%

+75.45K

+13.30%

Mar 31, 2025

持股ETF

更新时间: 9月2日周二

机构名称

占比

Global X HealthTech ETF

3.06%

Invesco S&P SmallCap Health Care ETF

2.48%

Simplify Health Care ETF

2.24%

Alger Mid Cap 40 ETF

2.03%

BNY Mellon Innovators ETF

1.96%

Fidelity Digital Health ETF

1.83%

SPDR S&P Health Care Equipment ETF

1.63%

First Trust Nasdaq Lux Digi Health Solutions ETF

1.35%

ETC 6 Meridian Small Cap Equity ETF

0.79%

Simplify Next Intangible Core Index ETF

0.75%

Global X HealthTech ETF

占比3.06%

Invesco S&P SmallCap Health Care ETF

占比2.48%

Simplify Health Care ETF

占比2.24%

Alger Mid Cap 40 ETF

占比2.03%

BNY Mellon Innovators ETF

占比1.96%

Fidelity Digital Health ETF

占比1.83%

SPDR S&P Health Care Equipment ETF

占比1.63%

First Trust Nasdaq Lux Digi Health Solutions ETF

占比1.35%

ETC 6 Meridian Small Cap Equity ETF

占比0.79%

Simplify Next Intangible Core Index ETF

占比0.75%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Inspire Medical Systems Inc

79.880USD

Inspire Medical Systems Inc

79.880

概览

公司

财务

分析